confidence in utilizing this drug to not only help improve patient quality of life, but also to help treat psoriasis in patients with different skin tones,” Chovatiya said. These findings are important as they demonstrate the effectiveness of guselkumab in diverse patient populations, providing further evidence of its potential as a treatment option for psoriasis. Chovatiya also discussed the importance of considering the impact of psoriasis on quality of life and how guselkumab may offer significant improvement in this area. The research presented at the Maui Derm 2024 meeting is a promising step forward in understanding the potential of guselkumab in treating psoriasis and improving patient outcomes.
Source link
VIDEO: Studies shed further light on guselkumab’s use for psoriasis
